South Korea
Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
The first eight months of 2025 have been transformative for biosupplier technologies worldwide. From innovative lab reagents and biomaterials to ad...
August 21, 2025 | Analysis
South Korea’s GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Plasma-Derived Medicines Workforce in Thailand
GC Biopharma , a South Korean biopharmaceutical company, announced that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Soc...
August 19, 2025 | News
South Korea’s Avixgen, Subsidiary of Dx&Vx, Signs $360M Licensing-Out Deal with U.S. Biotech for ACP Drug Delivery Platform
This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taki...
August 19, 2025 | News
Daewoong Korea’s Semaglutide Patch Achieves 80 Percent Bioavailability to Transform Obesity Care
More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and...
August 14, 2025 | News
South Korea’s Celltrion Secures U.S. FDA Approval to Expand AVTOZMA® IV for Cytokine Release Syndrome in Adults and Children
Approval of AVTOZMA® (tocilizumab-anoh) intravenous infusion expands label to include treatment of adults and pediatric patients aged 2 years an...
August 07, 2025 | News
iNtRON Bio Unveils World-First Dual-Action Engineered Phage Targeting Colorectal Cancer-Causing Bacteria
Successful validation of payloaded anti-colibactin toxin phage using IMPA™ technology • Demonstrated 'Dual-target Therapeut...
August 06, 2025 | News
South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech
Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...
July 31, 2025 | News
GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz
GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...
July 25, 2025 | News
Avantor Expands Regional Footprint with New Office in Suwon, South Korea
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies indust...
July 23, 2025 | News
South Korea Approves Clinical Trial of DeepQure’s HyperQure™ System for Atrial Fibrillation
DeepQure announced that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the c...
July 21, 2025 | News
GC Biopharma Secures Vietnam Approval for Antibiotic-Free Varicella Vaccine BARYCELA
GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from th...
July 18, 2025 | News
SK bioscience Pioneers Korea’s First Adjuvanted Flu Vaccine with IND Filing for NBP607B
Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2...
July 18, 2025 | News
SN BioScience’s Anticancer Candidate SNB-101 Selected for Korea’s 2025 National Drug Development Programme
SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, ...
July 17, 2025 | News
Illimis Therapeutics Raises Series B to Advance GAIA Platform for Alzheimer’s and Immune Disorders
The Series B round saw strong participation from both existing and new investors, demonstrating high industry confidence in Illimis Therapeutics' visi...
July 15, 2025 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
